RESTRICTED TO EDITORIAL USE - A picture

RESTRICTED TO EDITORIAL USE - A picture taken on June 9, 2011 in a pharmacy in Dijon, eastern France, shows a pack of Actos antidiabetic drugs (Pioglitazone). Actos/Competact antidiabetic drugs from Takeda Japanese laboratory, responsible of a significant increase of bladder cancer for men, are "immediately banned form the market" in France, as reported on June 9, 2011 by Dominique Maraninchi, head of French Afssaps drug agency. AFP PHOTO / JEFF PACHOUD (Photo credit should read JEFF PACHOUD/AFP via Getty Images)
RESTRICTED TO EDITORIAL USE - A picture taken on June 9, 2011 in a pharmacy in Dijon, eastern France, shows a pack of Actos antidiabetic drugs (Pioglitazone). Actos/Competact antidiabetic drugs from Takeda Japanese laboratory, responsible of a significant increase of bladder cancer for men, are "immediately banned form the market" in France, as reported on June 9, 2011 by Dominique Maraninchi, head of French Afssaps drug agency. AFP PHOTO / JEFF PACHOUD (Photo credit should read JEFF PACHOUD/AFP via Getty Images)
RESTRICTED TO EDITORIAL USE - A picture
ACQUISTA UNA LICENZA
Come posso utilizzare questa immagine?
475,00 €
EUR

DETTAGLI

Restrizioni:
Contatta l'ufficio locale per informazioni su qualsiasi tipo di uso commerciale o promozionale. Diritti editoriali illimitati per Regno Unito, Stati Uniti, Irlanda, Italia, Spagna, Canada (escluso Quebec). Diritti editoriali limitati in altri Paesi. Contatta l'ufficio locale.RESTRICTED TO EDITORIAL USE
Attestazione:
JEFF PACHOUD / Stringer
N. Editorial:
117298110
Collezione:
AFP
Data di creazione:
9 giugno 2011
Data di upload:
Tipo di licenza:
Rights-managed
Info sulla liberatoria:
Senza liberatoria. Ulteriori informazioni
Fonte:
AFP
Codice a barre:
AFP
Nome oggetto:
Par6322969
Max. dimensione file:
4256 x 2832 px (36,03 x 23,98 cm) - 300 dpi - 4 MB